Similares a Keynote Address: Tracy Beth Høeg (FDA CDER Acting Director) - NORD Scientific Symposium

20 vecinos (text_768) · 153 views · National Organization for Rare Disorders (NORD) · Estados Unidos


★	Keynote Address: Tracy Beth Høeg (FDA CDER Acting Director) - NORD Scientific Symposium	National Organization for Rare Disorders (NORD) @raredisorders	153	Estados Unidos
2	Dr. Vinay Prasad Keynote Address - NORD Scientific Symposium	National Organization for Rare Disorders (NORD) @raredisorders	814	Estados Unidos	87
18	GDF2026 - Updates on Nitrosamines/ Nitrosamine Mitigation Strategies for Pharmaceuticals	U.S. Food and Drug Administration @us_fda	409	Estados Unidos	84
14	GDF2026 - Q&A Discussion Panel Eight	U.S. Food and Drug Administration @us_fda	298	Estados Unidos	84
9	GDF2026 - Q&A Discussion Panel Six	U.S. Food and Drug Administration @us_fda	292	Estados Unidos	84
1	Understanding the FDA's Plausible Mechanism Framework	National Organization for Rare Disorders (NORD) @raredisorders	276	Estados Unidos	87
10	GDF2026 - Q&A Discussion Panel Four and Day One Closing	U.S. Food and Drug Administration @us_fda	187	Estados Unidos	84
4	NORD® Rare Disease Scientific Symposium 2025	National Organization for Rare Disorders (NORD) @raredisorders	173	Estados Unidos	85
8	GDF2026 - Office of Generic Drugs (OGD) Keynote	U.S. Food and Drug Administration @us_fda	144	Estados Unidos	84
3	Leveraging Innovative Trial Designs and Technologies to Accelerate - NORD Scientific Symposium	National Organization for Rare Disorders (NORD) @raredisorders	129	Estados Unidos	86
17	GDF2026 - Best Practices for Safety Assessment of Nitrosamines in Generic Drugs	U.S. Food and Drug Administration @us_fda	127	Estados Unidos	84
11	GDF2026 - An Update on CDER’s Quality Management Maturity (QMM) Program	U.S. Food and Drug Administration @us_fda	109	Estados Unidos	84
5	GDF2026 - Office of Pharmaceutical Quality (OPQ) Keynote	U.S. Food and Drug Administration @us_fda	101	Estados Unidos	85
7	Registries and Real World Data as Development Platforms - NORD Scientific Symposium	National Organization for Rare Disorders (NORD) @raredisorders	99	Estados Unidos	84
15	Keynote Address: Annica Wayman, PhD, NIH – NORD Scientific Symposium	National Organization for Rare Disorders (NORD) @raredisorders	93	Estados Unidos	84
6	Learn How to Support Our Rare Disease Citizen Petition to the FDA	National Organization for Rare Disorders (NORD) @raredisorders	76	Estados Unidos	85
16	GDF2026 - Q&A Discussion Panel Three	U.S. Food and Drug Administration @us_fda	72	Estados Unidos	84
12	What’s Next in Rare Disease Data Collection and Clinical Use - NORD Scientific Symposium	National Organization for Rare Disorders (NORD) @raredisorders	70	Estados Unidos	84
20	GDF2026 - FDA Commissioner Keynote	U.S. Food and Drug Administration @us_fda	66	Estados Unidos	83
13	GDF2026 - Standardized Principles Used to Determine Maximum Daily Dose	U.S. Food and Drug Administration @us_fda	57	Estados Unidos	84
19	GDF2026 - Decoding PSGs for Complex Non-Oral Generics	U.S. Food and Drug Administration @us_fda	49	Estados Unidos	83